A detailed history of Hsbc Holdings PLC transactions in Incyte Corp stock. As of the latest transaction made, Hsbc Holdings PLC holds 1,246,927 shares of INCY stock, worth $88.6 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,246,927
Previous 1,240,952 0.48%
Holding current value
$88.6 Million
Previous $75.2 Million 9.56%
% of portfolio
0.05%
Previous 0.05%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$57.33 - $68.61 $342,546 - $409,944
5,975 Added 0.48%
1,246,927 $82.4 Million
Q2 2024

Aug 12, 2024

BUY
$51.18 - $63.75 $3.34 Million - $4.16 Million
65,300 Added 5.55%
1,240,952 $75.2 Million
Q1 2024

May 15, 2024

BUY
$56.55 - $66.59 $8.88 Million - $10.5 Million
156,946 Added 15.41%
1,175,652 $67 Million
Q4 2023

Feb 12, 2024

SELL
$52.16 - $64.19 $5.14 Million - $6.32 Million
-98,489 Reduced 8.82%
1,018,706 $64 Million
Q3 2023

Nov 13, 2023

BUY
$57.77 - $65.93 $154,996 - $176,890
2,683 Added 0.24%
1,117,195 $64.5 Million
Q2 2023

Aug 11, 2023

BUY
$60.95 - $75.51 $7.48 Million - $9.27 Million
122,700 Added 12.37%
1,114,512 $69.4 Million
Q1 2023

May 15, 2023

BUY
$70.23 - $86.01 $37.8 Million - $46.3 Million
538,279 Added 118.69%
991,812 $71.7 Million
Q4 2022

Feb 14, 2023

SELL
$67.18 - $84.11 $11.1 Million - $13.9 Million
-164,900 Reduced 26.66%
453,533 $36.4 Million
Q3 2022

Nov 14, 2022

BUY
$66.18 - $82.86 $15.4 Million - $19.3 Million
233,326 Added 60.59%
618,433 $41.4 Million
Q2 2022

Aug 11, 2022

BUY
$66.18 - $83.18 $1.01 Million - $1.27 Million
15,278 Added 4.13%
385,107 $29.3 Million
Q1 2022

May 16, 2022

BUY
$66.02 - $79.71 $11.8 Million - $14.2 Million
178,183 Added 92.98%
369,829 $29.5 Million
Q4 2021

Feb 11, 2022

BUY
$63.34 - $74.11 $344,506 - $403,084
5,439 Added 2.92%
191,646 $0
Q3 2021

Nov 12, 2021

BUY
$68.67 - $84.02 $1.64 Million - $2 Million
23,855 Added 14.69%
186,207 $12.8 Million
Q2 2021

Aug 13, 2021

BUY
$79.87 - $87.53 $1.48 Million - $1.62 Million
18,508 Added 12.87%
162,352 $0
Q1 2021

May 14, 2021

SELL
$76.02 - $100.5 $2.05 Million - $2.71 Million
-26,979 Reduced 15.79%
143,844 $0
Q4 2020

Feb 25, 2021

SELL
$80.74 - $97.7 $5.32 Million - $6.44 Million
-65,900 Reduced 27.84%
170,823 $0
Q4 2020

Feb 12, 2021

BUY
$80.74 - $97.7 $8.56 Million - $10.4 Million
106,067 Added 81.18%
236,723 $0
Q3 2020

Nov 12, 2020

BUY
$85.07 - $109.69 $1.21 Million - $1.56 Million
14,250 Added 12.24%
130,656 $11.6 Million
Q2 2020

Aug 14, 2020

SELL
$74.18 - $108.93 $1.04 Million - $1.53 Million
-14,012 Reduced 10.74%
116,406 $12.1 Million
Q1 2020

May 15, 2020

SELL
$63.18 - $85.97 $1.07 Million - $1.45 Million
-16,869 Reduced 11.45%
130,418 $9.48 Million
Q4 2019

Feb 14, 2020

BUY
$73.04 - $95.72 $3.45 Million - $4.52 Million
47,273 Added 47.27%
147,287 $12.9 Million
Q3 2019

Nov 14, 2019

BUY
$72.82 - $86.52 $461,824 - $548,709
6,342 Added 6.77%
100,014 $7.42 Million
Q2 2019

Aug 13, 2019

BUY
$73.52 - $88.7 $213,943 - $258,117
2,910 Added 3.21%
93,672 $7.96 Million
Q1 2019

May 15, 2019

BUY
$63.56 - $88.17 $508,289 - $705,095
7,997 Added 9.66%
90,762 $7.81 Million
Q4 2018

Feb 13, 2019

SELL
$58.5 - $69.94 $686,322 - $820,536
-11,732 Reduced 12.42%
82,765 $5.26 Million
Q3 2018

Nov 13, 2018

SELL
$61.75 - $74.23 $1.62 Million - $1.94 Million
-26,201 Reduced 21.71%
94,497 $6.53 Million
Q2 2018

Aug 10, 2018

SELL
$60.85 - $83.98 $1.98 Million - $2.73 Million
-32,561 Reduced 21.25%
120,698 $8.09 Million
Q1 2018

May 11, 2018

BUY
$83.06 - $100.98 $1.17 Million - $1.42 Million
14,092 Added 10.13%
153,259 $12.8 Million
Q4 2017

Feb 14, 2018

SELL
$93.56 - $116.6 $838,297 - $1.04 Million
-8,960 Reduced 6.05%
139,167 $13.2 Million
Q3 2017

Nov 14, 2017

BUY
$109.15 - $138.27 $1.82 Million - $2.3 Million
16,670 Added 12.68%
148,127 $17.3 Million
Q2 2017

Aug 14, 2017

BUY
N/A
131,457
131,457 $16.6 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.8B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.